Hemolytic anemia occurs approximately 10 times more frequently with fifth-generation SAPIEN 3 Ultra RESILIA (S3UR) valves than with the third-generation SAPIEN 3 (S3), despite the newer valve showing less paravalvular leak, an analysis of data from Japanese patients suggests.